Literature DB >> 7187746

Friend leukemia as a multiple-step disease.

P Tambourin, F Wendling, F Moreau-Gachelin.   

Abstract

The results presented here indicate that erythroleukemia induced by Friend virus evolve by multistage processes. The early phase of Friend disease is characterized by a rapid increase in the number of erythroblastic cells with limited proliferative capacity. The second phase is associated with the appearance of malignant cells with extensive proliferative capacity and autonomous growth. Friend leukemia appears to be a valuable model for studying the sequence of modifications occurring in cells progressing from a normal state to a preneoplastic and finally a highly malignant one.

Entities:  

Mesh:

Year:  1981        PMID: 7187746

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  7 in total

1.  Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia.

Authors:  David Cervi; Yuval Shaked; Mehran Haeri; Tatiana Usenko; Christina R Lee; Jody J Haigh; Andras Nagy; Robert S Kerbel; Eitan Yefenof; Yaacov Ben-David
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

Review 2.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Integration of spleen focus-forming virus proviruses in Friend tumor cells.

Authors:  F Moreau-Gachelin; J Robert-Lezenes; F Wendling; A Tavitian; P Tambourin
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Analysis of integrated proviral DNA sequences with an octadecanucleotide probe designed for specific identification of spleen focus-forming virus in the mouse genome.

Authors:  F Moreau-Gachelin; L D'Auriol; J Robert-Lezenes; F Galibert; P Tambourin; A Tavitian
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.

Authors:  K J Hasenkrug
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells.

Authors:  Yuval Shaked; Dave Cervi; Manuela Neuman; Limor Chen; Giannoula Klement; Crystal R Michaud; Mehran Haeri; Brian J Pak; Robert S Kerbel; Yaacov Ben-David
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

Review 7.  Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation.

Authors:  Françoise Moreau-Gachelin
Journal:  Retrovirology       Date:  2008-11-04       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.